News
The U.S. Food and Drug Administration extended the review of KalVista Pharmaceuticals' drug for a type of hereditary swelling ...
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial ...
The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer. The ...
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that the ...
The U.S. Food and Drug Administration (FDA) has issued a recall of millions of eggs from the August Egg Company that had the ...
US FDA pauses Gilead trials testing experimental HIV pill combination The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...
Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...
RAD101 is the Company's novel imaging small molecule that targets fatty acid synthase (FASN), a multi-enzyme protein that ...
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
A popular Breyers ice cream flavor sold nationwide is being recalled due to an undeclared allergen, according to the U.S.
today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for RAD101 to distinguish between recurrent disease and treatment effect of brain metastases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results